By Dan Goldstein (dan.goldstein@tueoris.com), Co-founder and Partner, Tueoris, LLC – www.tueoris.com It’s a well-known fact in the life sciences world that data collected today in a clinical trial can have …
GDPR
EU Personal Data Transfers 2021: Planning for a Year of Increased Scrutiny
By Dan Goldstein, Co-Founder, Tueoris, LLC and Daniela Fábián Masoch, Founder FABIAN PRIVACY LEGAL dan.goldstein@tueoris.com / www.tueoris.com daniela.fabian@privacylegal.ch / www.privacylegal.ch As 2021 begins, ex-EU transfers of personal data continue to …
GDPR Code of Conduct : Current State and Considerations for Next Steps
Since the EU General Data Protection Regulations (“GDPR”) came into effect in 2018, there has been much discussion, but little action, with regard to Article 40 Codes of Conduct (”Codes”) …
SCCs under Scrutiny: Transfer Strategies for US Companies Contracting with EU Service Providers
For many US-based multinational organizations, EU-approved Standard Contractual Clauses (“SCCs”) have long represented a relatively straightforward solution for the compliant transfer of personal data of EU residents to the organizations’ …
How to Prepare for SCC Scrutiny in a Post Schrems II World
Written by Dan Goldstein, Partner and Co-Founder of Tueoris, LLC In the aftermath of the EU Court of Justice’s Schrems II decision, multinational organizations in the US and around the …
Your Cookies Banners are Not Enough: How to Gain True Compliance with Cookies Requirements
It’s become increasingly clear that true compliance with applicable cookies requirements is no easy task. Sorting through the requirements of General Data Protection Regulation (“GDPR”), the ePrivacy Directive and now …
Facilitating Effective Responses to Data Subject Requests with Detailed Process Workflows
Organizations subject to global privacy regulations spend what often seems an exorbitant amount of time and resources to reach compliance objectives and keep up with constantly evolving privacy requirements. Data …
Alternatives to Consent: New Approaches to Processing Patient Data for Current and Future Clinical Research
Introduction Pharmaceutical and biotech companies sponsoring clinical research have traditionally relied on patient consent as the legal basis for processing personal data, sensitive personal data and biologic material for …